Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Advances Sales, Marketing, and Distribution Partnership in the Largest Market in World for Heart Disease: China

TheNewsWire February 16, 2021

Ventripoint Diagnostics Issues Shares in Final Payment of Debenture Interest

TheNewsWire February 10, 2021

Ventripoint Diagnostics Upgrades Investor Relations Webpage

TheNewsWire February 9, 2021

Correction: Ventripoint Accelerated Expiry Date of Warrants

TheNewsWire February 8, 2021

Ventripoint Issues Option Grants

TheNewsWire February 8, 2021

Ventripoint Hires MarketSmart Communications to Provide Investor Relations Services

TheNewsWire February 5, 2021

Ventripoint Announces Complete Conversion of Secured Convertible Debentures, Exercise of Warrants and Accelerated Expiry Date of Warrants

TheNewsWire February 3, 2021

Ventripoint Issues Option Grants and Exercises

TheNewsWire January 27, 2021

Ventripoint Diagnostics Issues Shares in Payment of Consulting Fees

TheNewsWire January 18, 2021

Ventripoint Announces Filing of Articles of Amendment

TheNewsWire January 13, 2021

Ventripoint Issues Option Grants

TheNewsWire January 13, 2021

Ventripoint Expands to Address the Needs of Companion Animals

TheNewsWire January 11, 2021

Kings College London Receives VMS+3.0 Ventripoint Whole Heart Analysis System

TheNewsWire January 4, 2021

Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting

TheNewsWire December 15, 2020

Ventripoint Diagnostics Receives Loan from FedDev Regional Relief and Recovery Fund and Reminds Shareholders about Annual General Meeting Today

TheNewsWire December 14, 2020

Ventripoint Diagnostics Receives Wage Subsidy

TheNewsWire December 10, 2020

Ventripoint Diagnostics Issues Shares in Payment of Debenture Interest, Consulting Fees and DSU Exercise

TheNewsWire November 26, 2020

Canada's Largest Cardiac Centre Receives VMS+3.0 Ventripoint Whole Heart Analysis System

TheNewsWire November 5, 2020

Ventripoint Engages Oak Hill Financial to Provide Investor Relations Services and Approval of Warrant Amendment

TheNewsWire November 3, 2020

Ventripoint Makes Application to Amend Warrrants

TheNewsWire October 9, 2020